Visus
1 products tracked · names used in filings: Visus
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 28 Jan 2026🇺🇸 FDA approval
FDA approves Yuvezzi (brimonidine tartrate, carbachol): new dosage form
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Yuvezzi brimonidine tartrate, carbachol | Approved | 2026-01-28 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.